Cybin Inc.

NYSE American CYBN

Cybin Inc. Dividend Yield on December 30, 2024: 0.00%

Cybin Inc. Dividend Yield is 0.00% on December 30, 2024, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Cybin Inc. 52-week high Dividend Yield is 0.00% on December 30, 2024, which is 0.00% below the current Dividend Yield.
  • Cybin Inc. 52-week low Dividend Yield is 0.00% on December 30, 2024, which is 0.00% below the current Dividend Yield.
  • Cybin Inc. average Dividend Yield for the last 52 weeks is 0.00%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
NYSE American: CYBN

Cybin Inc.

CEO Mr. Douglas L. Drysdale
IPO Date Sept. 13, 2019
Location Canada
Headquarters 100 King Street West
Employees 50
Sector Health Care
Industries
Description

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Similar companies

OPT

Opthea Limited

USD 3.82

6.70%

ATAI

Atai Life Sciences N.V.

USD 1.33

-6.34%

ZURA

Zura Bio Limited

USD 1.95

-2.01%

ITOS

iTeos Therapeutics, Inc.

USD 7.66

-1.80%

FBIO

Fortress Biotech, Inc.

USD 1.90

-3.55%

EWTX

Edgewise Therapeutics, Inc.

USD 27.52

8.65%

MNMD

Mind Medicine (MindMed) Inc.

USD 6.40

-1.54%

ZVSA

ZyVersa Therapeutics, Inc.

USD 1.49

12.03%

BPTH

Bio-Path Holdings, Inc.

USD 0.84

-10.07%

VCNX

Vaccinex, Inc.

USD 1.05

0.00%

IMMX

Immix Biopharma, Inc.

USD 2.00

-5.66%

GHRS

GH Research PLC

USD 8.19

-1.92%

StockViz Staff

January 15, 2025

Any question? Send us an email